ConductScience.org, home

Paper39512331

Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.

Kaur G and 2 others. Biophys Rev (Melville), 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications. Papers, record 39512331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39512331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.
PubMed
Journal
Biophys Rev (Melville)
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.47, provisional
iCite
Revised in PubMed
2025-11-06
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kaur GGeetikahttps://orcid.org/0000-0003-0988-4503
2Bisen SShivantikahttps://orcid.org/0009-0003-8922-0519
3Singh NKNikhlesh Khttps://orcid.org/0000-0002-3665-6023

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 EY004068NEI NIH HHSUnited StatesP30EY004068PubMedNIH RePORTER
R01 EY029709NEI NIH HHSUnited StatesR01EY029709PubMedNIH RePORTER

Download CSV of grants

References143

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129459654Photoelectrochemical modulation of neuronal activity with free-standing coaxial silicon nanowires.Nat Nanotechnol2018https://conductscience.org/library/papers/29459654PubMed
237887287Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods.Cells2023https://conductscience.org/library/papers/37887287PubMed
337814270Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation.Mol Cancer2023https://conductscience.org/library/papers/37814270PubMed
437514191Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases.Pharmaceutics2023https://conductscience.org/library/papers/37514191PubMed
518686775Drug delivery and nanoparticles:applications and hazards.Int J Nanomedicine2008https://conductscience.org/library/papers/18686775PubMed
626606532Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium.PLoS One2015https://conductscience.org/library/papers/26606532PubMed
731581687Single-Crystalline Metal Oxide Nanostructures Synthesized by Plasma-Enhanced Thermal Oxidation.Nanomaterials (Basel)2019https://conductscience.org/library/papers/31581687PubMed
833277608Engineering precision nanoparticles for drug delivery.Nat Rev Drug Discov2021https://conductscience.org/library/papers/33277608PubMed
929379334Applications of nanoparticle systems in drug delivery technology.Saudi Pharm J2018https://conductscience.org/library/papers/29379334PubMed
1025066531Yttrium oxide nanoparticles prevent photoreceptor death in a light-damage model of retinal degeneration.Free Radic Biol Med2014https://conductscience.org/library/papers/25066531PubMed
1124451140Magnetic nanoparticles as intraocular drug delivery system to target retinal pigmented epithelium (RPE).Int J Mol Sci2014https://conductscience.org/library/papers/24451140PubMed
1223826539Nanoparticles in the ocular drug delivery.Int J Ophthalmol2013https://conductscience.org/library/papers/23826539PubMed
1330797953Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/30797953PubMed
1425695336Ocular tissue engineering: current and future directions.J Funct Biomater2015https://conductscience.org/library/papers/25695336PubMed
1529986546Human 3D Cultures as Models for Evaluating Magnetic Nanoparticle CNS Cytotoxicity after Short- and Repeated Long-Term Exposure.Int J Mol Sci2018https://conductscience.org/library/papers/29986546PubMed
1635494641Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds.Front Chem2022https://conductscience.org/library/papers/35494641PubMed
1727233037Survival and Functionality of hESC-Derived Retinal Pigment Epithelium Cells Cultured as a Monolayer on Polymer Substrates Transplanted in RCS Rats.Invest Ophthalmol Vis Sci2016https://conductscience.org/library/papers/27233037PubMed
1834641139Hyaluronic Acid-Based Gold Nanoparticles for the Topical Delivery of Therapeutics to the Retina and the Retinal Pigment Epithelium.Polymers (Basel)2021https://conductscience.org/library/papers/34641139PubMed
1930827682Mammalian Near-Infrared Image Vision through Injectable and Self-Powered Retinal Nanoantennae.Cell2019https://conductscience.org/library/papers/30827682PubMed
2020877651Structure-function correlation of the human central retina.PLoS One2010https://conductscience.org/library/papers/20877651PubMed

See all 143 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
42005706
Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials.
Int J Nanomedicine2026https://conductscience.org/library/papers/42005706PubMed
41331389Multifunctional nanoplatforms for optic nerve regeneration integrating anti-inflammatory, epigenetic, and ionic mechanisms with emerging artificial intelligence technologies.Cell Biol Toxicol2025https://conductscience.org/library/papers/41331389PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39512331

GET https://conductscience.org/api/papers/v1/39512331/references?page=2